Boditech Med Inc
KOSDAQ:206640
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Boditech Med Inc
Income from Continuing Operations
Boditech Med Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Boditech Med Inc
KOSDAQ:206640
|
Income from Continuing Operations
₩27.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Income from Continuing Operations
-₩6.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Income from Continuing Operations
₩132B
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
115%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Income from Continuing Operations
₩29.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Income from Continuing Operations
₩32.6B
|
CAGR 3-Years
94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Income from Continuing Operations
-₩8.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boditech Med Inc
Glance View
Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2014-12-29. The firm is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 1998 and is located in Chuncheon-si, Gang-won-do, South Korea.
See Also
What is Boditech Med Inc's Income from Continuing Operations?
Income from Continuing Operations
27.4B
KRW
Based on the financial report for Sep 30, 2025, Boditech Med Inc's Income from Continuing Operations amounts to 27.4B KRW.
What is Boditech Med Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-4%
Over the last year, the Income from Continuing Operations growth was 0%. The average annual Income from Continuing Operations growth rates for Boditech Med Inc have been 1% over the past three years , -4% over the past five years .
